Genome-Wide Association Studies have identified several loci associated with breast cancer (BC) in populations of different ethnic origins. One of the strongest associations was found in the FGFR2 gene, and MAP3K1 has been proposed as a low-penetrance BC risk factor. In this study, we evaluated the associations among FGFR2 SNPs rs2981582, rs2420946, and rs1219648; and MAP3K1 rs889312, with BC risk in 351 BRCA1/2-negative Chilean BC cases and 802 controls. All the SNPs studied were significantly associated with increased BC risk in familial BC and in non-familial early-onset BC, in a dose-dependent manner. Subjects with 3 risk alleles were at a significantly increased risk of BC compared with subjects with 0–2 risk alleles, in both familial BC and early-onset non-familial BC (OR = 1.47, 95 % CI 1.04–2.07, P = 0.026 and OR = 2.04 95 % CI 1.32–3.24, P < 0.001, respectively). In the haplotype analysis, the FGFR2 rs2981582 T / rs2420946 T / rs1219648 G haplotype (ht2) was associated with a significantly increased BC risk compared with the rs2981582 C / rs2420946 C / rs1219648 A haplotype in familial BC and in non-familial early-onset BC (OR = 1.32, 95 % CI 1.06–1.65, P = 0.012; OR = 1.46, 95 % CI 1.11–1.91, P = 0.004, respectively). When the FGFR2 ht2 and MAP3K1 rs889312 were evaluated as risk alleles, the risk of BC increased in a dose-dependent manner as the number of risk alleles increased (P trend <0.0001), indicating an additive effect. Nevertheless, there is no evidence of an interaction between FGFR2 ht2 and the MAP3K1 rs889312 C allele. These findings suggest that genetic variants in the FGFR2 and MAP3K1 genes may contribute to genetic susceptibility to BC.
Breast cancer Polymorphism FGFR2MAP3K1
This is a preview of subscription content, log in to check access.
The authors thank the families who participated in the research studies described in this article. We acknowledge the Breast Cancer Group of CONAC: Maria Teresa Barrios, Angelica Soto, Rossana Recabarren, Leticia Garcia, Karen Olmos, and Paola Carrasco; and Lorena Seccia for her technical assistance. Authors received the grant sponsor from Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT)/Corporación Nacional del Cáncer. Grant number: 1110081.
Easton DF, Pooley KA, Dunning AM, Pharoah PDP, Thompson D, Ballinger DG et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087–1093. doi:10.1038/nature05887PubMedCrossRefGoogle Scholar
Ingersoll RG, Paznekas WA, Tran AK, Scott AF, Jiang G, Jabs EW (2001) Fibroblast growth factor receptor 2 (FGFR2): genomic sequence and variations. Cytogenet Cell Genet 94:121–126. doi:10.1159/000048802PubMedCrossRefGoogle Scholar
Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE et al (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39:870–874. doi:10.1038/ng2075PubMedCrossRefGoogle Scholar
Huijts PEA, Vreeswijk MPG, Kroeze-Jansema KHG, Jacobi CE, Seynaeve C, Krol-Warmerdam EMM et al (2007) Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a dutch cohort of incident breast cancer cases. Breast Cancer Res 9:R78. doi:10.1186/bcr1793PubMedCrossRefGoogle Scholar
Liang J, Chen P, Hu Z, Zhou X, Chen L, Li M et al (2008) Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis 29:2341–2346. doi:10.1093/carcin/bgn235PubMedCrossRefGoogle Scholar
Hemminki K, Müller-Myhsok B, Lichtner P, Engel C, Chen B, Burwinkel B et al (2010) Low-risk variants FGFR2, TNRC9 and LSP1 in german familial breast cancer patients. Int J Cancer 126:2858–2862. doi:10.1002/ijc.24986PubMedGoogle Scholar
Barnholtz-Sloan JS, Shetty PB, Guan X, Nyante SJ, Luo J, Brennan DJ et al (2010) FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in african-american and younger women. Carcinogenesis 31:1417–1423. doi:10.1093/carcin/bgq128PubMedCrossRefGoogle Scholar
Fu F, Wang C, Huang M, Song C, Lin S, Huang H (2012) Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women. Tohoku J Exp Med 226:221–229. doi:10.1620/tjem.226.221PubMedCrossRefGoogle Scholar
Slattery ML, Baumgartner KB, Giuliano AR, Byers T, Herrick JS, Wolff RK (2011) Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-hispanic white women living in the southwestern united states. Breast Cancer Res Treat 129:531–539. doi:10.1007/s10549-011-1498-yPubMedCrossRefGoogle Scholar
Lu P, Yang J, Li C, Wei M, Shen W, Shi L et al (2011) Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects. Breast Cancer Res Treat 126:663–670. doi:10.1007/s10549-010-1151-1PubMedCrossRefGoogle Scholar
Gonzalez-Hormazabal P, Gutierrez-Enriquez S, Gaete D, Reyes JM, Peralta O, Waugh E et al (2011) Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families. Breast Cancer Res Treat 126:705–716. doi:10.1007/s10549-010-1170-yPubMedCrossRefGoogle Scholar
Körkkö J, Annunen S, Pihlajamaa T, Prockop DJ, Ala-Kokko L (1998) Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci USA 95:1681–1685. doi:10.1073/pnas.95.4.1681PubMedCrossRefGoogle Scholar
Zhou L, Yao F, Luan H, Wang Y, Dong X, Zhou W et al (2012) Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis. Breast Cancer Res Treat. doi: 10.1007/s10549-012-2300-5
Udler MS, Meyer KB, Pooley KA, Karlins E, Struewing JP, Zhang J et al (2009) FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet 18:1692–1703. doi:10.1093/hmg/ddp078PubMedCrossRefGoogle Scholar
Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J et al (2008) Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci USA 105:4340–4345. doi:10.1073/pnas.0800441105PubMedCrossRefGoogle Scholar
Chen F, Lv M, Xue Y, Zhou J, Hu F, Chen X et al (2012) Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality. Immunogenetics 64:71–76. doi:10.1007/s00251-011-0564-2PubMedCrossRefGoogle Scholar
Esteban Cardeñosa E, de Juan Jiménez I, Palanca Suela S, Chirivella González I, Segura Huerta A, Santaballa Beltran A et al (2012) Low penetrance alleles as risk modifiers in familial and sporadic breast cancer. Fam Cancer 11:629–636. doi:10.1007/s10689-012-9563-1PubMedCrossRefGoogle Scholar
Cruz-Coke R (1976) Origen y evolución étnica de la población chilena. Rev Med Chil 104:365–368PubMedGoogle Scholar
Valenzuela C, Harb Z (1977) Socioeconomic assortative mating in Santiago, Chile: as demonstrated using stochastic matrices of mother-child relationships applied to abo blood groups. Soc Biol 24:225–233PubMedGoogle Scholar